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This special issue of Prostate Cancer was designed to be
read by both urologists and pathologists. It comprises eight
papers, of which 3 are original studies and 5 are review
papers, largely devoted to promoting urologists’ understand-
ing of the histologic ﬁndings provided by pathologists in
both biopsy and radical prostatectomy specimens.
Many of the papers are closely related and fall into 4
general subheadings: (1) technical implications of biopsy
sampling and submission; (2) correlation of histoarchitec-
tural ﬁndings with tumor development and outcome; (3)
prognostic factors; (4) tumor biology.
Biopsy sampling and submission technique is addressed in
one original article and one review article. D. Parada et al.
emphasize the cost savings attainable by inking needle cores
from various sites submitted in the same block. Galosi et al.
review their work and that of others on the beneﬁts of inking
the peripheral end of each core for orientation and stage
prediction.
Correlationofhistoarchitecturalﬁndingswithtumordevel-
opment is explored in an original study and a review. K. A.
Iczkowski et al. based their study on the observation that not
all prostate cancers graded as Gleason 4 look alike. Thus,
a quantitative analysis of the density of cancer epithelial
cells compared with stroma and the loss of ability to form a
lumen (spaces in cancer are termed pseudolumens) may give
us additional, cost-eﬀective information to stratify outcomes
more ﬁnely. The review by R. Nagle and B. Cress ties in
with the Iczkowski study, by postulating that loss of polarity
and the ability to form lumens are key measures of tumor
aggressiveness. They review the literature and postulate
that tubule formation, rather than epithelial-mesenchymal
transition (EMT) is the main driver of invasion and metasta-
sis.
Prognostic factors are covered in three review articles.
Kotb et al. provide an overview of prognostic factors with
respect to recurrence. Iczkowski and Lucia review prostatec-
tomymarginstatus,akeypredictorofoutcomewhoseimpli-
cations may not be well understood by urologists. The loca-
tion, extent, and grade of margin positivity, it turns out, can
modify its importance. P. Furtado et al. review the outcome
of a particularly aggressive variant of prostate cancer called
small cell carcinoma. This constitutes fewer than 1% of
prostate cancers and, importantly, tends not to elevate serum
PSA.
Finally, the tumor biology of prostate cancer is studied by
P. N. Werahera et al. using molecular techniques to estimate2 Prostate Cancer
tumor doubling time. They postulate a role for apoptosis in
determining tumor aggressiveness.
We are pleased to present this compendium of papers
containing the most contemporary thought regarding the
submission of specimens, new insights on histologic mor-
phology, prognostic implications of ﬁndings, and tumor
biology. We hope we have stimulated urologists to under-
stand and take interest in these up-to-the-minute develop-
ments in pathology that aﬀect their practice.
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